$1.21 Billion is the total value of Vident Investment Advisory, LLC's 472 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NWSA | Exit | NEWS CORP NEWcl a | $0 | – | -10,507 | -100.0% | -0.01% | – |
| REI | Exit | RING ENERGY INC | $0 | – | -24,639 | -100.0% | -0.03% | – |
| PLOW | Exit | DOUGLAS DYNAMICS INC | $0 | – | -9,064 | -100.0% | -0.03% | – |
| USB | Exit | US BANCORP DEL | $0 | – | -5,671 | -100.0% | -0.03% | – |
| IEX | Exit | IDEX CORP | $0 | – | -3,252 | -100.0% | -0.03% | – |
| XLNX | Exit | XILINX INC | $0 | – | -5,184 | -100.0% | -0.03% | – |
| TSC | Exit | TRISTATE CAP HLDGS INC | $0 | – | -12,823 | -100.0% | -0.03% | – |
| CDK | Exit | CDK GLOBAL INC | $0 | – | -4,583 | -100.0% | -0.03% | – |
| SYY | Exit | SYSCO CORP | $0 | – | -5,855 | -100.0% | -0.03% | – |
| ANGI | Exit | ANGIES LIST INC | $0 | – | -54,993 | -100.0% | -0.03% | – |
| YHOO | Exit | YAHOO INC | $0 | – | -6,804 | -100.0% | -0.03% | – |
| LOGM | Exit | LOGMEIN INC | $0 | – | -3,222 | -100.0% | -0.03% | – |
| CMCSA | Exit | COMCAST CORP NEWcl a | $0 | – | -8,583 | -100.0% | -0.03% | – |
| ATRC | Exit | ATRICURE INC | $0 | – | -16,881 | -100.0% | -0.03% | – |
| DIS | Exit | DISNEY WALT CO | $0 | – | -2,931 | -100.0% | -0.03% | – |
| ORCL | Exit | ORACLE CORP | $0 | – | -7,451 | -100.0% | -0.03% | – |
| DY | Exit | DYCOM INDS INC | $0 | – | -3,690 | -100.0% | -0.03% | – |
| VIXY | Exit | PROSHARES TR IIvix short term f | $0 | – | -25,800 | -100.0% | -0.03% | – |
| BMCH | Exit | BMC STK HLDGS INC | $0 | – | -15,065 | -100.0% | -0.03% | – |
| CGEN | Exit | COMPUGEN LTDord | $0 | – | -150,614 | -100.0% | -0.06% | – |
| SRNE | Exit | SORRENTO THERAPEUTICS INC | $0 | – | -170,534 | -100.0% | -0.07% | – |
| LBIO | Exit | LION BIOTECHNOLOGIES INC | $0 | – | -125,536 | -100.0% | -0.09% | – |
| SCHE | Exit | SCHWAB STRATEGIC TRemrg mkteq etf | $0 | – | -47,400 | -100.0% | -0.11% | – |
| NLNK | Exit | NEWLINK GENETICS CORP | $0 | – | -80,649 | -100.0% | -0.19% | – |
| TSO | Exit | TESORO CORP | $0 | – | -31,212 | -100.0% | -0.25% | – |
| DV | Exit | DEVRY ED GROUP INC | $0 | – | -73,994 | -100.0% | -0.26% | – |
| XRX | Exit | XEROX CORP | $0 | – | -366,929 | -100.0% | -0.27% | – |
| MBBYF | Exit | MOBILEYE N V AMSTELVEEN | $0 | – | -65,298 | -100.0% | -0.40% | – |
| ESLT | Exit | ELBIT SYS LTDord | $0 | – | -38,206 | -100.0% | -0.43% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NVIDIA CORPORATION | 35 | Q2 2023 | 1.8% |
| UNITEDHEALTH GROUP INC | 35 | Q2 2023 | 1.0% |
| MICROSOFT CORP | 35 | Q2 2023 | 1.2% |
| ELEVANCE HEALTH INC | 35 | Q2 2023 | 0.6% |
| AMGEN INC | 35 | Q2 2023 | 0.7% |
| AT&T INC | 35 | Q2 2023 | 0.7% |
| WAL-MART STORES INC | 35 | Q2 2023 | 0.8% |
| MERCK & CO INC NEW | 35 | Q2 2023 | 1.0% |
| BRISTOL-MYERS SQUIBB CO | 35 | Q2 2023 | 0.4% |
| QUEST DIAGNOSTICS INC | 35 | Q2 2023 | 0.4% |
View Vident Investment Advisory, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
| 40-APP | 2021-11-10 |
View Vident Investment Advisory, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.